U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07628153) titled 'Mindfulness and Biofeedback for Anxiety Disorders' on June 01.
Brief Summary: This randomized controlled trial compared the effectiveness of a 10-day mindfulness training program using adaptive biofeedback (BFB) versus medication therapy (escitalopram 10 mg/day) versus combined treatment (BFB + medication) in inpatients with anxiety disorders (ICD-10 F40/F41). The primary outcomes were changes in anxiety (Hamilton Anxiety Rating Scale, HARS) and mindfulness (Five Facet Mindfulness Questionnaire, FFMQ) from baseline to post-treatment and at one-month follow-up.
Study Start Date: July 11, 2022
Study Type: INTERVENTIONAL
Condition: ...